Hydrolytically Labile Linkers Regulate Release and Activity of Human Bone Morphogenetic Protein-6

Langmuir. 2018 Aug 7;34(31):9298-9306. doi: 10.1021/acs.langmuir.8b00853. Epub 2018 Jul 26.

Abstract

Release of growth factors while simultaneously maintaining their full biological activity over a period of days to weeks is an important issue in controlled drug delivery and in tissue engineering. In addition, the selected strategy to immobilize growth factors largely determines their biological activity. Silica surfaces derivatized with glycidyloxy propyl trimethoxysilane and poly(glycidyl methacrylate) brushes yielded epoxide-functionalized surfaces onto which human bone morphogenetic protein-6 (hBMP-6) was immobilized giving stable secondary amine bonds. The biological activity of hBMP-6 was unleashed by hydrolysis of the surface siloxane and ester bonds. We demonstrate that this type of labile bonding strategy can be applied to biomaterial surfaces with relatively simple and biocompatible chemistry, such as siloxane, ester, and imine bonds. Our data indicates that the use of differential hydrolytically labile linkers is a versatile method for functionalization of biomaterials with a variety of growth factors providing control over their biological activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials / chemistry*
  • Bone Morphogenetic Protein 6 / chemistry
  • Bone Morphogenetic Protein 6 / metabolism*
  • Humans
  • Hydrolysis
  • Silicon Dioxide / chemistry*
  • Tissue Engineering

Substances

  • BMP6 protein, human
  • Biocompatible Materials
  • Bone Morphogenetic Protein 6
  • Silicon Dioxide